Prothena Corporation PLC reports results for the quarter ended in September - Earnings Summary

Prothena

02/11/2023 23:00

* Prothena Corporation PLC  PRTA.OQ  reported quarterly
adjusted
earnings of 38 cents​​ per share for the quarter ended in
September, higher than the same quarter last year, when the
company reported EPS of -97 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 32 cents per
share. Wall Street expected results to range from $-1.39 to 3
cents per share.
    * Revenue rose 5,494.3% to $84.87 million from a year ago;
analysts expected $41.69 million. 
    * Prothena Corporation PLC's reported EPS for the quarter
was 38
cents​.
    * The company reported quarterly net income of $21.91
million.
    * Prothena Corporation PLC shares had fallen by 24.0% this
quarter and lost 39.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 66.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Prothena
Corporation PLC is $86.50 
This summary was machine generated from LSEG data November 2 at
11:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.32          0.38           Beat
 Jun. 30 2023      -1.00          -1.03          Missed
 Mar. 31 2023      -0.94          -0.89          Beat
 Dec. 31 2022      -0.47          0.12           Beat